Literature DB >> 1696868

The neuropeptide substance P stimulates the effector functions of platelets.

M Damonneville1, D Monté, C Auriault, A Capron.   

Abstract

Sensory neuropeptides, such as substance P, appear as potent mediators of various immunological reactions, and inhibit or stimulate a wide range of functions of immune inflammatory cells. Platelets were recently shown to participate as effector cells in an IgE or lymphokine-dependent killing of parasites. Substance P and its carboxy-terminal fragment SP (4-11) induce the cytotoxic activity of platelets towards the larvae of Schistosoma mansoni, respectively, by 90% and 40%, whereas the modified C terminal SP, the SP-free acid, exhibits no effect on the platelets. The neuropeptide effects occur at low doses (10(-8) M), are specific as shown by inhibition studies with a substance P antagonist, the D-SP. Binding data obtained after flow cytofluorometry with FITC-SP lead to the conclusion that SP binds specifically to about 20% of the homogenous population of platelets. Moreover, IgE could modulate the SP-dependent functions of platelets since the pre-incubation with myeloma human IgE or with AP2 monoclonal antibodies--known to inhibit the IgE-dependent killing of these cells-leads to a dramatic decrease of the SP dependent cytotoxic activity of platelets towards the larvae. These findings identify a potent mechanism for nervous system regulation of host defence responses.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1696868      PMCID: PMC1535063          DOI: 10.1111/j.1365-2249.1990.tb03343.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  Bernard-Soulier syndrome: a new platelet glycoprotein abnormality. Its relationship with platelet adhesion to subendothelium and with the factor VIII von Willebrand protein.

Authors:  J P Caen; A T Nurden; C Jeanneau; H Michel; G Tobelem; S Levy-Toledano; Y Sultan; F Valensi; J Bernard
Journal:  J Lab Clin Med       Date:  1976-04

2.  An unidentified depressor substance in certain tissue extracts.

Authors:  U S V Euler; J H Gaddum
Journal:  J Physiol       Date:  1931-06-06       Impact factor: 5.182

3.  New functions for platelets and their pathological implications.

Authors:  A Capron; J C Ameisen; M Joseph; C Auriault; A B Tonnel; J Caen
Journal:  Int Arch Allergy Appl Immunol       Date:  1985

4.  Substance P: binding properties and studies on cellular responses in guinea pig macrophages.

Authors:  H P Hartung; K Wolters; K V Toyka
Journal:  J Immunol       Date:  1986-05-15       Impact factor: 5.422

5.  Induction of platelet cytotoxic functions by lymphokines: role of interferon-gamma.

Authors:  V Pancre; M Joseph; C Mazingue; J Wietzerbin; A Capron; C Auriault
Journal:  J Immunol       Date:  1987-06-15       Impact factor: 5.422

6.  Recombinant tumor necrosis factors mediate platelet cytotoxicity to Schistosoma mansoni larvae.

Authors:  M Damonneville; J Wietzerbin; V Pancré; M Joseph; A Delanoye; A Capron; C Auriault
Journal:  J Immunol       Date:  1988-06-01       Impact factor: 5.422

7.  Specific stimulation of human T lymphocytes by substance P.

Authors:  D G Payan; D R Brewster; E J Goetzl
Journal:  J Immunol       Date:  1983-10       Impact factor: 5.422

8.  The receptor for IgE on blood platelets.

Authors:  M Joseph; A Capron; J C Ameisen; M Capron; H Vorng; V Pancré; J P Kusnierz; C Auriault
Journal:  Eur J Immunol       Date:  1986-03       Impact factor: 5.532

9.  Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferations by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen.

Authors:  A M Stanisz; D Befus; J Bienenstock
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

10.  Effect of neuropeptides on production of inflammatory cytokines by human monocytes.

Authors:  M Lotz; J H Vaughan; D A Carson
Journal:  Science       Date:  1988-09-02       Impact factor: 47.728

View more
  2 in total

1.  Separate induction of human blood platelet aggregation or cytotoxicity by different concentrations of PAF-acether and thrombin.

Authors:  A Tran; D Vanhée; A Capron; H Vorng; P Braquet; M Joseph
Journal:  Agents Actions       Date:  1992-05

Review 2.  Future innovations in anti-platelet therapies.

Authors:  N E Barrett; L Holbrook; S Jones; W J Kaiser; L A Moraes; R Rana; T Sage; R G Stanley; K L Tucker; B Wright; J M Gibbins
Journal:  Br J Pharmacol       Date:  2008-04-21       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.